Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Thymoglobulin® Versus Grafalon® in Renal Transplantation - Spiesser Group (Retro/Prospective Study) I

NCT03996278 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03996278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Thymoglobulin® Versus Grafalon® in Renal Transplantation - Spiesser Group (Retro/Prospective Study) I
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Unknown status
Start date
May 22, 2019
Completion date
November 22, 2021
Enrollment
300 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation